IP Library › Granted Patent US 7,736,884
Granted Patent B2
US 7,736,884 · App. 11/146,428 · Granted Jun 15, 2010

Metabolically engineered

Assignee: Fluxome Sciences A/S
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,736,884
App. No.
11/146,428
Granted
Jun 15, 2010
Kind
B2
Abstract

The present invention relates to the construction and engineering of cells, more particularly microorganisms for producing PUFAs with four or more double bonds from non-fatty acid substrates through heterologous expression of an oxygen requiring pathway. The invention especially involves improvement of the PUFA content in the host organism through fermentation optimization, e.g. decreasing the temperature and/or designing an optimal medium, or through improving the flux towards fatty acids by metabolic engineering, e.g. through over-expression of fatty acid synthases, over-expression of other enzymes involved in biosynthesis of the precursors for PUFAs, or codon optimization of the heterologous genes, or expression of heterologous enzymes involved in the biosynthesis of the precursor for PUFAs.

Claims (29)

1. A genetically modified Saccharomyces cerevisiae capable of producing polyunsaturated fatty acids with four or more double bonds when grown on a non-fatty acid substrate, wherein said Saccharomyces cerevisiae comprises heterologous expression of nucleotide sequences encoding delta-12 desaturase, delta-6 desaturase, delta-6 elongase, delta-5 desaturase and delta-9 desaturase; wherein said heterologous expression increases the content of polyunsaturated fatty acids with four or more double bonds to more than 1.1% of the total fatty acid content in said Saccharomyces cerevisiae.

2. A genetically modified Saccharomyces cerevisiae capable of producing polyunsaturated fatty acids with four or more double bonds when grown on a non-fatty acid substrate, wherein said Saccharomyces cerevisiae comprises heterologous expression of nucleotide sequences encoding delta-12 desaturase, delta-9 elongase, delta-8 desaturase, delta-5 desaturase, and delta-9 desaturase, wherein said heterologous expression increases the content of polyunsaturated fatty acids with four or more double bonds to more than 1.1% of the total fatty acid content in said Saccharomyces cerevisiae.

3. A method for producing polyunsaturated fatty acids with four or more double bonds comprising heterologous expression of an oxygen requiring pathway in a Saccharomyces cerevisiae grown on a non-fatty acid substrate, wherein the heterologous expression comprises combining heterologous expression of nucleotide sequences encoding delta-12 desaturase, delta-6 desaturase, delta-6 elongase, delta-5 desaturase, and delta-9 desaturase, wherein said heterologous expression increases the content of polyunsaturated fatty acids with four or more double bonds to more than 1.1% of the total fatty acid content in said Saccharomyces cerevisiae.

4. A method for producing polyunsaturated fatty acids with four or more double bonds comprising heterologous expression of an oxygen requiring pathway in a Saccharomyces cerevisiae grown on a non-fatty acid substrate, wherein the heterologous expression comprises combining heterologous expression of nucleotide sequences encoding delta-12 desaturase, delta-9 elongase, delta-8 desaturase, delta-5 desaturase, and delta-9 desaturase, wherein said heterologous expression increases the content of polyunsaturated fatty acids with four or more double bonds to more than 1.1% of the total fatty acid content in said Saccharomyces cerevisiae.

5. A method according to claim 3 or 4 , wherein the heterologous expression further comprises combining heterologous expression of nucleotide sequences encoding delta-5 elongase, omega-3 desaturase, and/or delta-4 desaturase.

6. A method according to claim 5 ,

wherein said combined heterologous expression further comprises an over-expression of at least one of the genes selected from the group consisting of genes encoding the acetyl-CoA carboxylase designated ACC1, the β-ketoacyl-CoA reductase designated YBR159W, the fatty acid synthase a subunit designated FAS1, the fatty acid synthase β subunit designated FAS2, the enoyl reductase designated TSC13, the L-glycerol-phosphate acyltransferase designated GAT1, the 1-acylglycerol-3-phosphate acyltransferase designated SLC1 and the pantothenate kinase designated YDR531W; or

wherein said combined heterologous expression further comprises a deletion of at least one of the genes selected from the group consisting of genes encoding the glyceraldehydes-3-phosphate dehydrogenase designated GDH1 and the peroxisomal acyl-CoA oxidase designated POX1, or

wherein said combined heterologous expression further comprises a heterologous expression of nucleotide sequences encoding ATP:citrate lyase subunits.

7. A method according to claim 3 or 4 , wherein said heterologous nucleotide sequences are codon optimized for expression in Saccharomyces cerevisiae ; or wherein said Saccharomyces cerevisiae is cultivated in a myo-inositol deficient medium.

8. A method according to claim 3 or 4 , wherein the polyunsaturated fatty acid is selected from the group consisting of arachidonic acid, eicosapentaenoic acid, and docosahexaenoic acid.

9. A method according to claim 6 , wherein said heterologous expression increases the content of arachidonic acid, eicosapentaenoic acid, and/or docosahexaenoic acid to more than 3% of the total fatty acid content in said Saccharomyces cerevisiae.

10. A method for producing a polyunsaturated fatty acid comprising the steps of

(a) isolating at least five nucleotide sequences encoding a delta-12 desaturase a delta-6 desaturase a delta-6 elongase, a delta-5 desaturase, and a delta-9 desaturase exogenous to Saccharomyces cerevisiae,

(b) constructing one or more vectors comprising said isolated nucleotide sequences of step (a) and/or integrating said isolated nucleotide sequences into the genome of Saccharomyces cerevisiae;

(c) growing said Saccharomyces cerevisiae on a non-fatty acid substrate, whereby said non-fatty acid substrate is converted by said host into a desired polyunsaturated fatty acid product and obtaining said polyunsaturated fatty acid,

wherein heterologous expression of said five isolated nucleotide sequences increases the content of the polyunsaturated fatty acid to more than 1.1% of the total fatty acid content in said Saccharomyces cerevisiae.

11. A method for producing a polyunsaturated fatty acid comprising the steps of

(a) isolating at least five nucleotide sequences encoding a delta-12 desaturase, a delta-9 elongase, a delta-8 desaturase, a delta-5 desaturase and a delta-9 desaturase exogenous to Saccharomyces cerevisiae,

(b) constructing one or more vectors comprising said isolated nucleotide sequences of step (a) and/or integrating said isolated nucleotide sequences into the genome of Saccharomyces cerevisiae;

(c) growing said Saccharomyces cerevisiae on a non-fatty acid substrate, whereby said non-fatty acid substrate is converted by said host into a desired polyunsaturated fatty acid product and obtaining said polyunsaturated fatty acid,

wherein heterologous expression of said five isolated nucleotide sequences increases the content of the polyunsaturated fatty acid to more than 1.1% of the total fatty acid content in said Saccharomyces cerevisiae.

12. A method according to claim 10 or 11 , wherein the heterologous expression further comprises heterologous expression of a nucleotide sequence encoding delta-9 desaturase, delta-5 elongase, omega-3 desaturase, and/or delta-4 desaturase.

13. A composition comprising a genetically modified Saccharomyces cerevisiae comprising a nucleotide sequence encoding each of an heterologous delta-12 desaturase, delta-6 desaturase, delta-6 elongase, delta-5 desaturase, and delta-9 desaturase, and having a polyunsaturated fatty acid content of more than 1.1% of the total fatty acid content, wherein the polyunsaturated fatty acid has four or more double bonds.

14. A composition according to claim 13 , wherein the polyunsaturated fatty acid comprises arachidonic acid, eicosapentaenoic acid and/or docosahexaenoic acid.

15. The composition of claim 13 , wherein the polyunsaturated fatty acid content is more than 3% of the total fatty acid content.

16. A food product comprising the composition of claim 13 .

17. A cosmetic product comprising the composition of claim 13 .

18. A feed comprising the composition of claim 13 .

Assignments (2)
CHANGE OF ASSIGNEE'S ADDRESS Recorded Aug 7, 2006
From: FLUXOME SCIENCES A/S
To: FLUXOME SCIENCES A/S
Reel/Frame 018073/0047 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2006
From: GUNNARSSON, NINA KATARINA; FORSTER, JOCHEN; NIELSEN, JENS BREDAL
To: FLUXOME SCIENCES A/S
Reel/Frame 016989/0443 →
Continuity (2)
Provisional Application 6057724500 · Jun 4, 2004
Related Publication 20060051847A1 · Mar 9, 2006